Navigation Links
Zyprexa in Medical News

Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices

PHILADELPHIA, Jan. 15 /PRNewswire/ -- Eli Lilly and Company announced today it has agreed to plead guilty to criminal conduct and to pay more than 1.4 billion in criminal and civil fines, penalties and damages arising from allegations made in multiple whistleblower lawsuits that the pharmaceutical...

Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices

INDIANAPOLIS, Jan. 15 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today announced that it has reached resolution with the United States Attorney for the Eastern District of Pennsylvania (EDPA) and the Office of Consumer Litigation of the Department of Justice regarding the p...

State of Alaska and Eli Lilly and Company Reach Agreement to Settle Zyprexa Lawsuit

INDIANAPOLIS, Ind. and ANCHORAGE, Alaska, March 26 /PRNewswire/ -- Eli Lilly and Company and the State of Alaska have agreed on the following joint statement: Alaska Attorney General Talis J. Colberg and Eli Lilly and Company (NYSE: LLY ) today announced a settlement of the lawsuit filed by...

Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels

INDIANAPOLIS, Oct. 5 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced today that as a part of on-going discussions with the U.S. Food and Drug Administration (FDA), the company has updated the Zyprexa(R) (olanzapine) and Symbyax(R) (olanzapine and fluoxetine HCl) U.S. product labels. ...

Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa

$515 Million Criminal Fine is Largest Individual Corporate Criminal Fine in History; Civil Settlement Up To $800 Million WASHINGTON, Jan. 15 /PRNewswire-USNewswire/ -- American pharmaceutical giant Eli Lilly and Company today agreed to plead guilty and pay $1.415 billion for promoting it...

Abilify Has Made Strong Gains in Patient Share Across All Lines of Therapy Since Last Year's Analysis of Prescribing Trends in Schizophrenia

...grew substantially compared with our 2008 analysis whereas both Eli Lilly's zyprexa and AstraZeneca's Seroquel lost first-line patient share," stated Nicole We...arly lines of therapy, surveyed psychiatrists indicate that risperidone and zyprexa will lose the most share. These data indicate that marketers of current and...

Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance

... $1.06 $.88 20% Charge related to zyprexa litigation .06 - Restruc...99.7 million of Erbitux revenue. zyprexa In the second quarter of 2009, zyprexa sales totaled $1.203 billion, a decrease of 3 perc...

FDA Panel OKs Newer Antipsychotics for Children

... Seroquel, zyprexa and Geodon have been linked to certain health risks, experts note,, WEDNESDAY, June 10 (HealthDay News) -- A U.S. Food and Drug Administra...

FDA Panel Mulls Newer Antipsychotics for Kids

... Seroquel, zyprexa have been linked to certain health risks, experts note,, WEDNES...ity, and finally, physicians may continue prescribing Geodon, Seroquel, and zyprexa off-label to children, as we continue to grow this knowledge base." In a...

Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting

...ral population. Safety information for Oral zyprexa (olanzapine) zyprexa is indicated in adults in the United States for th...maintenance treatment of bipolar disorder. zyprexa is not approved for the treatment of patients with...
Zyprexa in Medical Technology

FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

ADELPHI, Md., June 10 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) voted that Zyprexa(R) (olanzapine), an atypical antipsychotic, is effective and acceptably safe for the acute treatment of schizophrenia or manic or mix...

FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults

...l comorbidities than the general population. Safety information for zyprexa zyprexa oral is indicated in the United States for the short- and long- term treatm...

Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release

...disservice to patients who may currently be taking zyprexa to treat a life-threatening disease. Specifically,...eir doctor. -- Patients can get information about zyprexa by contacting the LillyAnswers Center at 1-800-LillyRx (1-800-545-5979) or going to the zyprexa website at http://www.zyprexa.com . ...

FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment

...Lilly and Company (NYSE: LLY ) announced today. zyprexa LAI is an investigational formulation that combines the atypical antipsychotic medication zyprexa (olanzapine) with a pamoate salt, resulting in an ...nical trials showed greater symptom improvement in zyprexa LAI-treated patients, compared with those on place...
Zyprexa in Biological News

FDA Warns About Antipsychotic Drugs and Elderly

...ith their use compared to patients receiving a placebo (sugar pill). Today's advisory applies to such antipsychotic drugs as Abilify (aripiprazole), zyprexa (olanzapine), Seroquel (quetiapine), Risperdal (risperidone), Clozaril (clozapine) and Geodon (ziprasidone). Symbyax, which is approved for treatment ...
Zyprexa in Biological Technology

Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance

...all cell lung cancer and advanced, metastatic head and neck cancer. zyprexa continues to provide a stable revenue base, despite generic competition in ...itutional market volume is growing for the first time in five years. Future zyprexa sales should benefit from a long-acting formulation, olanzapine LAI, which ...

Lilly to Take Charge to Earnings Related to Pending Federal and State Investigations of Past Practices

...ed to past marketing and promotional practices for zyprexa in the United States. Lilly has now incorporated a...eneral counsel. "The government's investigation of zyprexa has been ongoing for five years and we now have a ...) related to the sales, marketing and promotion of zyprexa for $62 million. In March, Lilly entered into a $1...

Lilly Reports Solid Second-Quarter Results

... response to the FDA's not-approvable decision for zyprexa long-acting injection. -- The FDA approved Strat... ---- Zyprexa In the second quarter of 2008, zyprexa sales totaled $1.240 billion, a 2 percent increase...both net selling prices and volume was negligible. zyprexa sales in international markets increased 4 percent...

Lilly Reports Solid First-Quarter Results

...he U.S. Food and Drug Administration (FDA) for zyprexa long-acting injection for the treatment and ma...ettle a lawsuit filed by the state over use of zyprexa by the state's Medicaid program. The agreement...s, including a $15.0 million settlement related to zyprexa litigation with the state of Alaska. Research and ...

Manhattan Research Ranks the Top Pharmaceutical Branded Websites by Rx Request Rates

...sperdal, Rozerem, Seasonale, Seroquel, Singulair, Strattera, Tamiflu, Topamax, Toprol XL, Tricor, Valtrex, Vytorin, Yasmin, Yaz, Zocor, Zoloft, Zomig, zyprexa and Zyrtec. Please visit http://www.manhattanresearch.com/ePC.htm to download the ePharma Consumer(R) product brochure, request subscription infor...

Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer

...f therapy, largely owing to its first-in-class status among the antipsychotics to treat both mania and depression. Janssen's Risperdal and Eli Lilly's zyprexa suffered the greatest losses, losing a combined 11.9% patient share first line over the same time period. About Treatment Algorithm Insight Series D...

Big Pharma's continued hunger and search for new products

...spiratory Disorders/Asthma $5.6 +19% 5. Zocor Merck) Cholesterol Reduction $5.3 6. Norvasc (Pfizer) Hypertension/Angina $5.0 +3% 7. zyprexa (Eli Lily) Antidepressant $4.7 8. Risperdal (Janssen- Ortho/J&J) Anti-psychotic Agent $4.0 +13% 9. Prevacid (Abbott/Takeda) Gastrointes...
Other Tags
(Date:4/21/2015)... Somerset, NJ & New York, NY (PRWEB) April ... the leading global provider of advanced delivery technologies ... health products, today announced the launch of ADVASEPT™ ... the safe and efficient delivery of injectable medications. ... syringe, combining a safe, convenient and functional container ...
(Date:4/21/2015)... Spokane, WA (PRWEB) April 21, 2015 ... Medical Practice Edition 2 for otolaryngologists, bringing the ... in the healthcare community. Otolaryngologists can now ... backed by a trusted source in the industry, ... successful integration with leading EHRs. , “Lyft is ...
(Date:4/21/2015)... April 21, 2015 QuickMedical, a ... and supplies, now represents Schiller America's ... ECGs, Stress Tests, and Vital Signs Monitors, among ... Switzerland, is a global leader in the development ... are developed in close cooperation with the world's ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 On April ... Awards” EcoLuxe Lounge at the world famous Avalon Hollywood. ... sustainable product placement in TV and film, the EcoLuxe ... appearances at many awards ceremonies and festivals throughout the ... providers of eco-friendly and socially conscious products and services, ...
(Date:4/21/2015)... The 2015 Market Research Report on ... and in-depth study on the current state of ... a focus on the Chinese situation. , ... research are Cargill, Fbc Industries, Posy Pharmachem, Fuso, ... Lianyungang Mupro Fi, Yixing-Union, Debang Fine Chemical, Shuren ...
Breaking Medicine News(10 mins):Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:Lyft Expands Its Offerings to Include Dragon® Medical Practice Edition 2 for Otolaryngologists. 2Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Hollywood's Santana Dempsey and Choices Recovery South Bend Examine Victory over Personal Struggles 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3
(Date:4/14/2015)... OXFORD, Conn. , April 14, 2015 ... "Company"), a biometric authentication company focused on the growing ... has been nominated for the 2015 New York Design ... The Design100, New York City Design Awards are ... are based on over 2,500 ratings from the marketplace, ...
(Date:4/8/2015)... 8, 2015  Infinisource, a leading provider of SaaS-based ... Morpho, a leading supplier of biometric identification and ... market,s most advanced biometrically-enabled time clock, the companies ... clock is setting a bold, new standard for ... the small and mid-size employer. When connected to ...
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... for its touch fingerprint sensor FPC1025 from the distributor ... Deliveries will commence during Q2 2015 although the major ... 2015. The sensors will be used by smartphone manufacturers ... of 110 MSEK is included in the communicated revenue ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
Other Contents